此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effect of Prostatic Urethra and Seminal Vesicle Morphometry on Ejaculation

2026年5月30日 更新者:SEZGIN、Başakşehir Çam & Sakura City Hospital

The Effect of Prostatic Urethral and Seminal Vesicle Morphometry on Multiparametric Prostate Magnetic Resonance Imaging on Ejaculation

The goal of this observational study is to learn whether the size and shape of the prostatic urethra and seminal vesicles - measured on multiparametric prostate MRI (mpMRI) - are related to premature ejaculation (PE) severity in men aged 18-55.

The main questions it aims to answer are:

  • Do men with premature ejaculation have different prostatic urethral length and angulation compared to men without PE?
  • Do men with premature ejaculation have different seminal vesicle dimensions compared to men without PE?
  • Do prostatic urethra and seminal vesicle measurements on mpMRI correlate with PE severity scores (PEDT) and ejaculation latency time (IELT)?

Researchers will compare men with premature ejaculation to healthy men without ejaculatory complaints to see if specific anatomical features are associated with PE severity.

Participants will:

  • Undergo a multiparametric prostate MRI that is already scheduled as part of their routine medical care
  • Complete validated questionnaires about ejaculation and sexual function (PEDT, PEP, IELT, IIEF-15)
  • Provide a blood sample for routine hormone level measurements

研究概览

地位

尚未招聘

条件

详细说明

Premature ejaculation (PE) is the most common male sexual dysfunction, affecting approximately 20-30% of men worldwide. Despite its high prevalence, its pathophysiology remains incompletely understood. While neurobiological and psychological factors have been extensively studied, the potential role of anatomical variations in the lower urinary tract

- specifically the prostatic urethra and seminal vesicles - has received limited attention in the literature.

The seminal vesicles play a key role in ejaculation by contributing approximately 70% of seminal fluid volume. Previous ultrasound-based studies have suggested a possible relationship between seminal vesicle size and PE severity. However, no study to date has investigated prostatic urethral and seminal vesicle morphometry using the superior spatial resolution of multiparametric prostate MRI (mpMRI) in relation to PE.

STUDY DESIGN:

Single-center, prospective, observational cohort study conducted at Başakşehir Çam ve Sakura City Hospital Urology Clinic, Istanbul, Turkey.

PARTICIPANTS:

150 men aged 18-55 years scheduled for clinically indicated mpMRI (elevated PSA or hematospermia) will be enrolled and divided into two cohorts:

  • PE Group: Men meeting ISSM criteria for lifelong PE (ejaculation within ~1 minute of vaginal penetration) or acquired PE (ejaculation within ~3 minutes of vaginal penetration), with inability to delay ejaculation and negative personal consequences.
  • Control Group: Healthy men without PE or any other sexual dysfunction complaint, with good ejaculatory control.

All participants must be in a stable heterosexual monogamous relationship with the same partner for at least 6 months and have normal erectile function (IIEF-15 erectile function domain score ≥26). Men using medications that may affect sexual function (SSRIs, PDE5 inhibitors) or those with hormonal disorders, major psychiatric conditions, or erectile dysfunction will be excluded.

MRI MORPHOMETRIC PARAMETERS:

The following measurements will be obtained from existing mpMRI images by the study urologists, without need for additional radiology support:

  • Prostatic urethral length (mm)
  • Prostatic urethral angulation (degrees)
  • Prostate posterior-anterior and lateral dimensions (mm)
  • Seminal vesicle anterior-posterior length (mm)
  • Seminal vesicle superior-anterior length (mm)
  • Seminal vesicle size to prostatic urethra size ratio
  • Prostate size to prostatic urethra size ratio

OUTCOME ASSESSMENTS:

  • Premature Ejaculation Diagnostic Tool (PEDT): range 0-20, higher scores indicate greater PE severity
  • Premature Ejaculation Profile (PEP): assesses ejaculatory control, distress, satisfaction, and interpersonal difficulty
  • Intravaginal Ejaculation Latency Time (IELT): recorded in seconds, lower values indicate greater PE severity
  • International Index of Erectile Function (IIEF-15): used to confirm normal erectile function and exclude erectile dysfunction
  • Serum hormone levels: total testosterone, TSH, prolactin
  • Demographic data: age, sexual abstinence duration

STATISTICAL ANALYSIS:

Continuous variables will be tested for normality using Shapiro-Wilk and Kolmogorov-Smirnov tests and expressed as mean ± standard deviation or median (min-max) accordingly. Group comparisons will be performed using Student t-test or Mann-Whitney U test for continuous variables and Chi-square or Fisher exact test for categorical variables.

Correlations between mpMRI morphometric parameters and PE severity (PEDT score, IELT) will be assessed using Pearson or Spearman correlation analyses. The primary analysis will use multiple linear regression to identify independent morphometric predictors of PE severity, with age, sexual abstinence duration, and hormone levels included as covariates. Multicollinearity will be assessed using variance inflation factor (VIF) and tolerance values.

Sample size was calculated using G*Power software (version 3.1.9.7) with medium effect size (f²=0.15), two-sided α=0.05, and 90% power, yielding a minimum of 123 participants. 150 participants will be enrolled to account for potential dropout.

All statistical analyses will be performed using IBM SPSS Statistics (version 30.0.0.0). Statistical significance will be set at p<0.05 (two-tailed).

No additional procedures beyond the clinically indicated mpMRI are required. The study poses no additional risk to participants.

研究类型

观察性的

注册 (估计的)

150

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

    • Istanbul
      • Istanbul、Istanbul、土耳其(türkiye)、34200
        • Başakşehir Çam and Sakura City Hospital, Department of Urology
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人

接受健康志愿者

是的

取样方法

非概率样本

研究人群

  • Any major psychiatric or somatic disorder
  • Hormonal disorders such as hypothyroidism or hyperthyroidism
  • Erectile dysfunction (IIEF-15 erectile function domain score <26)
  • Age below 18 or above 55 years

描述

Inclusion Criteria:

  • - Male aged 18 to 55 years
  • In a stable, heterosexual, monogamous relationship with the same female partner for at least 6 months
  • Normal erectile function defined as IIEF-15 erectile function domain score ≥26
  • Scheduled for clinically indicated multiparametric prostate MRI due to elevated PSA or hematospermia
  • Not using any medication that may affect sexual function or psychological status (e.g., SSRIs, PDE5 inhibitors)

Exclusion Criteria:

  • Any major psychiatric or somatic disorder
  • Hormonal disorders such as hypothyroidism or hyperthyroidism
  • Erectile dysfunction (IIEF-15 erectile function domain score <26)
  • Age below 18 or above 55 years

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
Premature Ejaculation
Men aged 18-55 years meeting ISSM criteria for lifelong or acquired premature ejaculation. Lifelong PE is defined as ejaculation occurring within approximately 1 minute of vaginal penetration since first sexual experience. Acquired PE is defined as ejaculation within approximately 3 minutes of vaginal penetration. All participants must have an inability to delay ejaculation and report negative personal consequences. Participants must have normal erectile function (IIEF-15 ≥26), be in a stable heterosexual monogamous relationship for at least 6 months, and have a clinically indicated mpMRI scheduled.
Control Group
Healthy men aged 18-55 years without premature ejaculation or any other sexual dysfunction complaint. Participants must have good ejaculatory control, normal erectile function (IIEF-15 ≥26), and be in a stable heterosexual monogamous relationship for at least 6 months. Participants must have a clinically indicated mpMRI scheduled due to elevated PSA or hematospermia.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Correlation Between Prostatic Urethral Length and Premature Ejaculation Severity
大体时间:At enrollment (single time point)
Pearson or Spearman correlation between prostatic urethral length measured on mpMRI (mm) and PEDT score. Higher PEDT score indicates greater PE severity (range 0-20).
At enrollment (single time point)
Correlation Between Seminal Vesicle Dimensions and Premature Ejaculation Severity
大体时间:At enrollment (single time point)
Pearson or Spearman correlation between seminal vesicle anterior-posterior length and superior-anterior length measured on mpMRI (mm) and PEDT score. Higher PEDT score indicates greater PE severity (range 0-20).
At enrollment (single time point)
Correlation Between Prostatic Urethral Angulation and Intravaginal Ejaculation Latency Time
大体时间:At enrollment (single time point)
Pearson or Spearman correlation between prostatic urethral angulation measured on mpMRI (degrees) and IELT (seconds). Lower IELT indicates greater PE severity.
At enrollment (single time point)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

有用的网址

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年5月10日

初级完成 (估计的)

2026年8月10日

研究完成 (估计的)

2026年8月10日

研究注册日期

首次提交

2026年5月22日

首先提交符合 QC 标准的

2026年5月22日

首次发布 (实际的)

2026年5月29日

研究记录更新

最后更新发布 (实际的)

2026年6月3日

上次提交的符合 QC 标准的更新

2026年5月30日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅